Knowledge Library

Introducing High-Quality and Cost-Effective R&D and GMP Plasmid DNA

WuXi Advanced Therapies Inc. (WuXi ATU) today announced the expansion of its Cell & Gene Therapy Platforms with capabilities to provide high-quality and cost-effective supplies of R&D and GMP Plasmid for use in a wide variety of R&D, clinical, and  commercial bioprocessing applications, with an integrated platform of capabilities that allows for a seamless single-source approach …Read More >

Resource Type: White Paper
Resource Topic: Clinical & Commercial Manufacturing

VIEW

WuXi Webinar on Spinal Muscular Atrophy

In order to promote the public’s awareness of rare diseases and showcase WuXi AppTec’s positive social impact, on Aug. 20, we organized a 3-session webinar series on Spinal Muscular Atrophy, including a fireside chat between Dr. David Chang, CEO of WuXi ATU, and Paulo Fontoura, Global Head and SVP, Neuroscience and Rare Diseases Clinical Development …Read More >

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Innovative Closed Process CAR-T cell therapy platform to streamline approach for manufacturing with great predictability

Date: May 19, 2020 Time: 11 am EDT | 8 am PDT | 5 pm CEST For many years, the primary forms of cancer treatment have been chemotherapy, radiation, and surgery. An amazing breakthrough known as chimeric antigen receptor (CAR) T-cell therapy is being studied in the treatment of various types of cancer, including acute and …Read More >

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing

VIEW

World-class AAV vector suspension platform to accelerate commercialization to market with greater predictability

WuXi Advanced Therapies launched a new world-class adenoassociated virus (AAV) vector suspension platform that complements integrated capabilities enabling cell and gene therapies to be developed, manufactured, and released faster and with greater predictability globally.

Resource Type: Webinar
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Interview: Accelerating advanced therapy pipelines and viral vector commercialisation

  In January, Phacilitate Leaders World & World Stem Cell Summit 2020 brought together the entire ecosystem of the advanced therapies industry from all corners of the globe to continue to build strong partnerships and collaborations to Miami, FL.  Phacilitate team spoke to Felix Hsu, Senior Vice President and Global Head at WuXi Advanced Therapies about strategically looking …Read More >

Resource Type: Article
Resource Topic: Clinical & Commercial Manufacturing

VIEW